Charles River Labs to lay off nearly 300 workers in Shrewsbury

January 11, 2010 by MassDevice staff

Wilmington, Mass.-based CRO Charles River Laboratories International plans to shutter its Shrewsbury, Mass., facility by the middle of 2010 and expects to take $7 million in restructuring charges during the first quarter as it sheds nearly 300 positions.

CRL logo

Charles River Laboratories International Inc. (NYSE:CRL) suspended operations at its preclinical services unit in Shrewsbury, a move that will result in about 300 layoffs.

About 30 of the 300 employees will be kept on to maintain the facility or be reassigned to other positions within the company, according to a spokeswoman for the Wilmington, Mass.-based contract research organization. Operations will resume at the facility when "global preclinical market conditions improve and the Company requires additional capacity," according to a press release.

The preclinical unit provides the services required to take a drug through the development process, including discovery support, toxicology, pathology, as well as Phase I clinical trials, according to the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.